Beam Therapeutics Inc. - Common Stock (BEAM)

Historical Holders from Q1 2020 to Q3 2025

Symbol
BEAM on Nasdaq
CUSIP
07373V105
Type / Class
Equity / Common Stock
Shares outstanding
101M
All holders as of June 30, 2025
Q2 2025
Total 13F shares, excl. options
108M
Holdings value
$1.84B
% of all portfolios
0.003%
Grand Portfolio weight change
+0%
Number of holders
214
Number of buys
115
Number of sells
-120
Average Value change %
0%
Average buys %
+0%
Average sells %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Beam Therapeutics Inc. - Common Stock (BEAM)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
FMR LLC 15% +49% $275M $92M 15.1M +50.2% FMR LLC Jun 30, 2025
ARK Investment Management LLC 10.35% +30.4% $190M $70.8M 10.4M +59.4% ARK Investment Management LLC Jul 31, 2025
Farallon Capital Partners, L.P. 9.99% +0.9% $154M $26.8M 9.97M +21% Dapice Joshua J. Mar 31, 2025
BlackRock, Inc. 7.5% $116M 7.5M BlackRock, Inc. Mar 31, 2025
ARCH Venture Fund IX, L.P. 4.6% -16.7% $71.2M 4.6M 0% Robert Nelsen Mar 31, 2025

Institutional Holders of Beam Therapeutics Inc. - Common Stock (BEAM)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 261 $6.33K -$10.5K $24.27 1
2025 Q2 108M $1.84B +$102M $17.01 214
2025 Q1 101M $1.98B +$387M $19.53 234
2024 Q4 81.4M $2.02B +$53.4M $24.80 228
2024 Q3 78.9M $1.93B +$31.9M $24.50 217
2024 Q2 77.5M $1.82B +$145M $23.43 210
2024 Q1 70M $2.31B +$41.8M $33.04 220
2023 Q4 64.1K $1.79M -$752K $27.22 3
2023 Q3 67.1M $1.61B +$71.8M $24.05 187
2023 Q2 63.9M $2.04B +$115M $31.93 188
2023 Q1 60.3M $1.85B +$135M $30.62 202
2022 Q4 55.8M $2.18B +$43.3M $39.11 202
2022 Q3 54.4M $2.59B -$482K $47.64 208
2022 Q2 54.5M $2.08B +$184M $38.71 185
2022 Q1 49.2M $2.82B +$204M $57.30 225
2021 Q4 45.5M $3.63B -$39M $79.69 222
2021 Q3 45.2M $3.93B -$59.5M $87.01 226
2021 Q2 45.4M $5.85B +$330M $128.71 225
2021 Q1 42.8M $3.42B +$467M $80.04 203
2020 Q4 36.9M $3.01B +$631M $81.64 150
2020 Q3 29.5M $727M +$39.4M $24.62 80
2020 Q2 27.7M $776M +$33.9M $28.00 70
2020 Q1 26.9M $484M +$484M $18.00 60